Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samu Melkko

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Medicinal Chemistry|November 20, 2020
Optimization of the <i>In Vivo</i> Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole BloodJean Quancard, Oliver Simic, Carole Pissot Soldermann, et al.
Journal of Medicinal Chemistry|November 30, 2020
Discovery of Potent, Highly Selective, and <i>In Vivo</i> Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold MorphingCarole Pissot Soldermann, Oliver Simic, Martin Renatus, et al.
Blood|January 30, 2019
MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humansAlexander W Koch, Nikolaus Schiering, Samu Melkko, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Medicinal Chemistry|November 20, 2020
Optimization of the <i>In Vivo</i> Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole BloodJean Quancard, Oliver Simic, Carole Pissot Soldermann, et al.
Journal of Medicinal Chemistry|November 30, 2020
Discovery of Potent, Highly Selective, and <i>In Vivo</i> Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold MorphingCarole Pissot Soldermann, Oliver Simic, Martin Renatus, et al.
Blood|January 30, 2019
MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humansAlexander W Koch, Nikolaus Schiering, Samu Melkko, et al.
Pageof 3